Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.22.2.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:        
Total revenue $ 1,557 $ 516 $ 3,567 $ 12,566
Operating expenses:        
Cost of product revenues 189 145 432 145
Research and development 6,430 4,401 19,410 16,083
Selling, general and administrative 16,739 15,411 47,001 34,879
Total operating expenses 23,358 19,957 66,843 51,107
Loss from operations (21,801) (19,441) (63,276) (38,541)
Other expense (income):        
Loss on extinguishment of debt 0 0 0 2,725
Amortization of debt issuance costs and discount 396 413 1,194 937
Interest income (531) (8) (724) (20)
Interest expense 1,379 1,019 3,669 1,678
Warrant liabilities fair value adjustment 6,497 (18,810) (13,215) (35,378)
Derivative liabilities fair value adjustment 42 (1,400) (1,120) (1,772)
Total other expense (income) 7,783 (18,786) (10,196) (31,830)
Loss before taxes (29,584) (655) (53,080) (6,711)
Income tax benefit 0 (50) (4,700) (3,088)
Net loss $ (29,584) $ (605) $ (48,380) $ (3,623)
Net loss per share attributable to common stockholders - basic        
Net loss per share - basic $ (0.62) $ (0.02) $ (1.18) $ (0.14)
Net loss per share attributable to common stockholders – diluted        
Net loss per share – diluted $ (0.62) $ (0.06) $ (1.18) $ (0.73)
Weighted average common shares outstanding – basic and diluted        
Basic 47,503,821 26,616,628 40,965,908 26,147,658
Diluted 47,503,821 27,754,828 40,965,908 26,326,006
Product Revenue, Net        
Revenue:        
Total revenue $ 1,557 $ 516 $ 3,567 $ 516
License Agreement Revenue        
Revenue:        
Total revenue $ 0 $ 0 $ 0 $ 12,050